Ketogenic Diet in Rheumatoid Arthritis (RA) (KETORA)
Rheumatoid Arthritis, Inflammation, Obesity
About this trial
This is an interventional basic science trial for Rheumatoid Arthritis
Eligibility Criteria
Inclusion Criteria: Diagnosis of RA according to the ACR/EULAR 2010 criteria for RA. On stable doses of DMARDs and/ or biological agents (≥ 2 months prior to study enrollment) Exclusion Criteria: Chronic inflammatory/ autoimmune disease other than RA (e.g. gout, inflammatory bowel disease such as Crohn's disease or ulcerative colitis, lupus, myositis, etc.) Prednisone or other glucocorticoid use in the last 4 weeks (exception: intra-articular glucocorticoid injections) Insulin use Hospitalization in the 30 days prior to study enrollment Acute or uncontrolled disease (e.g. cirrhosis, COPD, CKD) Malignancy Chronic infection (HIV, hep B/C, etc.) Heavy drinking On a ketogenic diet or exogenous ketone supplement (lses than 3 months prior to study enrollment) Recent weight loss (>5% in the last 2 months)
Sites / Locations
- Oklahoma University Health Sciences Center
Arms of the Study
Arm 1
Experimental
Ketogenic diet plan
Subjects will be provided extensive educational and ongoing support on the KD, including personalized coaching with the ability to text a dietitian at any time and expect a response within 12 hours. Diet adherence and progress will be assessed daily using at-home whole capillary blood ketone/glucose monitors, along with diet records. We will assess adherence based on days in ketosis following these parameters: (BHB ≥ 0.5mM). Adherence will be defined as > 80% of days in ketosis.